CENTRAL NERVOUS SYSTEM AGENTS

Clinical trials for CENTRAL NERVOUS SYSTEM AGENTS explained in plain language.

Never miss a new study

Get alerted when new CENTRAL NERVOUS SYSTEM AGENTS trials appear

Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a ketamine mist lift the fog of depression?

Symptom relief Recruiting now

This study tests whether inhaling ketamine through a nebulizer can reduce symptoms of moderate to severe depression in adults. Participants will receive either ketamine or a placebo (midazolam) and be monitored for changes in mood over about 10 days. The goal is to find a fast-ac…

Matched conditions: CENTRAL NERVOUS SYSTEM AGENTS

Phase: PHASE3 • Sponsor: Theresa Jacob, PhD, MPH • Aim: Symptom relief

Last updated May 06, 2026 16:02 UTC

CENTRAL NERVOUS SYSTEM AGENTS

Get alerted when new CENTRAL NERVOUS SYSTEM AGENTS trials appear

Could a ketamine mist lift the fog of depression?